BRAFv600E mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma

被引:8
|
作者
Jing Fan-jing [1 ]
Liang Jun [1 ]
Liang Zhi-yong [2 ]
Meng Chao [1 ]
Long Wen [3 ]
Li Xiao-yi [4 ]
Lin Yan-song [3 ]
机构
[1] Qingdao Univ, Qingdao Med Coll, Affiliated Hosp, Dept Oncol, Qingdao 266003, Shandong, Peoples R China
[2] Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China
[3] Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China
[4] Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
papillary thyroid carcinoma; B-RAF; neoplasm metastasis; vascular endothelial growth factor; BRAF MUTATION; CLINICAL-IMPLICATIONS; PROGNOSTIC-FACTORS; CANCER; SURVIVAL; OUTCOMES; EPIDEMIOLOGY; VEGF;
D O I
10.3760/cma.j.issn.0366-6999.20122032
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background BRAF(v600E) mutation is correlated with local aggressive clinicopathological features in papillary thyroid carcinoma; yet the relationship between this genetic variation and distant papillary thyroid carcinoma metastasis was unclear. This study aimed to investigate whether BRAF(v600E) is predictive for distant metastasis in the Chinese population. Methods One hundred and seven patients with papillary thyroid carcinoma were enrolled in this study, including 43 patients with distant metastasis and 64 patients without. Quantitative real-time polymerase chain reaction was used to detect BRAF(v600E) mutation, while immunohistochemistry was performed to detect vascular endothelial growth factor (VEGF) expression. The associations between distant metastasis and BRAF(v600E) mutation, and VEGF expression as well as local clinicopathological factors were determined. Results A total of 28.6% of the patients in the distant metastasis group harbored BRAF(v600E) mutation, which was significantly lower than in the without distant metastasis group (68.8%, P < 0.001). BRAF(v600E) mutation was negatively correlated with positive VEGF expression (P=0.001). Furthermore, 52.2% of the patients with distant metastasis exhibited VEGF expression, compared with 25.0% of those without. Higher levels of VEGF expression were also observed in the distant metastasis group. Tumor size, extra-thyroid invasion, and BRAF(v600E) mutation were independent predictors for distant metastasis according to multivariate analysis (odds ratios were 2.8, 12.4, and 0.3; 95% C/ 1.483-5.334, and 2.950-52.407, 0.100-0.890; P=0.002, 0.001, and 0.030, respectively). BRAF(v600E) mutation was negatively correlated with distant metastasis in adult subgroup analysis (P=0.005) but was not an independent parameter. Conclusions BRAF(v600E) mutation is predictive for distant metastasis in papillary thyroid carcinoma but not positively. VEGF may be involved in the pathogenesis of distant metastasis.
引用
下载
收藏
页码:3013 / 3018
页数:6
相关论文
共 50 条
  • [1] BRAFV600E Mutation Does Not Mean Distant Metastasis in Thyroid Papillary Carcinomas
    Sancisi, Valentina
    Nicoli, Davide
    Ragazzi, Moira
    Piana, Simonetta
    Ciarrocchi, Alessia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09): : E1745 - E1749
  • [2] Clinicopathological features and mutation of BRAFV600E in papillary thyroid carcinoma
    Suren, O.
    Malchinkhuu, M.
    Altangerel, Z.
    Dawaajargal, M.
    Munkhuu, P.
    Altanbayar, O.
    Baatarjalbuu, N.
    Bold-Erdene, A.
    Sharkhuu, E.
    Lkhagvadorj, S.
    Enkhbat, B.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S124 - S124
  • [3] Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma
    Kim, Yong-Seok
    Kim, Jeong-Soo
    Bae, Ja-Seong
    Park, Woo-Chan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
  • [4] The relevance of the BRAFV600E mutation in the treatment of the Papillary Thyroid Carcinoma
    Ajuria, O.
    Navarro Martinez, T.
    Lorente Castro, B.
    Castro Beiras, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S652 - S652
  • [5] Papillary Thyroid Carcinoma With BRAFV600E Mutation: Sonographic Prediction
    Hwang, Jiyoung
    Shin, Jung Hee
    Han, Boo-Kyung
    Ko, Eun Young
    Kang, Seok Seon
    Kim, Jong-Won
    Chung, Jae Hoon
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05) : W425 - W430
  • [6] Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma
    Yong-Seok Kim
    Jeong-Soo Kim
    Ja-Seong Bae
    Woo-Chan Park
    World Journal of Surgical Oncology, 11
  • [7] Is BRAFV600E mutation a marker for central nodal metastasis in small papillary thyroid carcinoma?
    Lang, Brian Hung-Hin
    Chai, Young Jun
    Cowling, Benjamin J.
    Min, Hye Sook
    Lee, Kyu Eun
    Youn, Yeo-Kyu
    ENDOCRINE-RELATED CANCER, 2014, 21 (02) : 285 - 295
  • [8] BRAFV600E and Recurrence in Papillary Carcinoma Thyroid
    Kumari, N.
    George, N.
    Shukla, P.
    Vishwakarma, R.
    Agarwal, A.
    Krishnani, N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 827 - 827
  • [9] Animal Model of the Papillary Thyroid Carcinoma Induced by BRAFV600E Mutation
    Rusinek, D.
    Chmielik, E.
    Kowal, M.
    Swierniak, M.
    Kowalska, M.
    Oczko-Wojciechowska, M.
    Przeorek, C.
    Widlak, W.
    Jarzab, B.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S166 - S167
  • [10] Expressions of miRNAs in papillary thyroid carcinoma and their associations with the BRAFV600E mutation
    Huang, Yongbo
    Liao, Denghui
    Pan, Lingxiao
    Ye, Runyi
    Li, Xiaoxi
    Wang, Shenming
    Ye, Caisheng
    Chen, Liuhua
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (05) : 675 - 681